Senior Translational Immuno-oncology/Small Molecule Consultant

Over three decades of translational drug discovery and R&D leadership for immuno-oncology, hematology, and autoimmune indications.

Well-versed in pushing pre-clinical immuno-oncology and hematology small molecules and immune inhibitory receptors into early Phase I studies.

Relevant Disease Areas

  • AML
  • Autoimmune diseases
  • Immuno-oncology
  • Hematology

Product Technologies

  • Immunomodulators
  • Monoclonal antibodies
  • Small Molecules
  • Solid Tumors

Recent Titles

  • VP, Research & Development
  • Director, Biology


  • Greater Boston Area
  • Open to remote and in-office

Relevant Companies

  • Sanofi-Genzyme

Relevant Skills

  • Translated discovery to clinical trials and market approval for 3 drugs
  • IND/NDA filings
  • Interfacing with business development for in-licensing and out-licensing opportunities
  • Novel drug target identification
  • Developing and managing pre-clinical in vivo pharmacology strategy

$375 / hr